Federal Ruling on Mifepristone Mail Delivery Impacts Abortion Access
A federal judge's ruling denies Louisiana's request to stop mail delivery of mifepristone, affecting abortion access nationwide amidst ongoing legal scrutiny.
Advocacy for Regulatory Flexibility in Rare Disease Therapies
Explore the urgent call for regulatory flexibility in rare disease therapies, as industry leaders seek solutions to expedite drug approvals amid strict FDA guidelines.